We validated the three candidate proteins using an additional larger sample number as a validation cohort, and finally proved that the two proteins IGFBP7 and SST were significantly regulated in CSF of MS patients, which is consistent with our proteomic results in the discovery cohort (Figure 4). The gene discussed is IGFBP7; the disease is myeloid sarcoma.